Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
2016
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
2017
Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ
2015
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
2013
Vitamin E Improves Transplant‐Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis
2018
XBP1s Is an Anti-lipogenic Protein
2016
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism
2017
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
2015
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
2012
Apical and Basal Regulation of the Permeability of the Retinal Pigment Epithelium
2003
Cytokines in inflammatory bowel disease
2014 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
2017
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis
2015
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
2015
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
2016
The tor pathway: a target for cancer therapy
2004 Standout
Hepatocellular carcinoma
2018 Standout
Leukocyte Diapedesis In Vivo Induces Transient Loss of Tight Junction Protein at the Blood–Retina Barrier
2005
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
2013
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
2018
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD )
2022
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
2012
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
2013
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
2013
Liver transplantation and non-alcoholic fatty liver disease
2014
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
2013
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
2013
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
2018
The Role of Cholesterol in the Pathogenesis of NASH
2015
Management of NAFLD: a stage-based approach
2016
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
2012
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
2017
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
A systematic review and a dose–response meta-analysis of coffee dose and nonalcoholic fatty liver disease
2018
Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
2018
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
2015
Hepatocellular carcinoma
2021 Standout
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Pathological Features of Fatty Liver Disease
2014
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
2012
Pharmacotherapy for NASH: Current and emerging
2017
NAFLD and diabetes mellitus
2016
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Regulation of glucose transporters during development of the retinal pigment epithelium
2000
An assessment by the Statin Liver Safety Task Force: 2014 update
2014
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
2014
Evidence for a Novel Marine Harmful Algal Bloom: Cyanotoxin (Microcystin) Transfer from Land to Sea Otters
2010
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
2012
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis
2015
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease
2013
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
2015
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
2017
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer
2019
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Insect pathogens as biological control agents: Back to the future
2015 Standout
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
2020
Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis
2014
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
2015
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
2013
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
The role of the gut microbiota in NAFLD
2016
Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?
2013
The genetics of NAFLD
2013
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
2015
Non-alcoholic steatohepatitis: a microbiota-driven disease
2013
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Non-alcoholic fatty liver disease and liver transplantation
2016
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
2018
Association of Coffee Intake With Reduced Incidence of Liver Cancer and Death From Chronic Liver Disease in the US Multiethnic Cohort
2014
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
2012
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Ulcerative colitis
2016 Standout
Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis
2021
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
2016
The global NAFLD epidemic
2013 Standout
Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice
2013
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
2020
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis
2013
NAFLD in Asia—as common and important as in the West
2013
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
2020
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants
2011
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
2015
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
2012
Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data
2017
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
2012
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
2021
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience
2015
Past, present and future perspectives in nonalcoholic fatty liver disease
2019
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
2019
Polarization of the Na+, K+-ATPase in Epithelia Derived from the Neuroepithelium
1998
Interactions Between the Intestinal Microbiome and Liver Diseases
2014
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
2012
Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis
2004
Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes
2018
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
2012
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
2017
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease
2018
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
2015
Gut microbiota in human metabolic health and disease
2020 Standout
Cyanobacterial blooms
2018 Standout
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Two secreted retinal factors regulate different stages of development of the outer blood–retinal barrier
2000
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Differential regulation of tight junction permeability during development of the retinal pigment epithelium
2000
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
2015
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
2016
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Prevalence of nonalcoholic fatty liver disease in mainland of C hina: A meta‐analysis of published studies
2013
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
2016
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
2014
Impact of coffee on liver diseases: a systematic review
2013
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study
2015
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
2017
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database
2018
Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells.
2003
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Is there an ‘ideal’ diet for patients with NAFLD?
2021
The association of nonalcoholic steatohepatitis and obstructive sleep apnea
2017
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
2019
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
2011
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
2017
Pharmacotherapy for Nonalcoholic Fatty Liver Disease
2015
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
2012
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
2018
Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
2019
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Steatosis and Steatohepatitis: Complex Disorders
2014
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2016
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Claudin-19 and the Barrier Properties of the Human Retinal Pigment Epithelium
2010
Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
2014
Nonalcoholic Steatohepatitis
2020
Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listing
2015
Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis
2016
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis
2016
The apical and basal environments of the retinal pigment epithelium regulate the maturation of tight junctions during development
2004
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
2012
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Practice patterns in NAFLD and NASH: real life differs from published guidelines
2015
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
2015
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
2013
Nonalcoholic Fatty Liver Disease
2015 Standout
Non‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
2017
The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer.
2005
Works of Christopher D. Williams being referenced
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Recreational exposure to microcystins during algal blooms in two California lakes
2009
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
2011
Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
2012
Association of Coffee and Caffeine Consumption With Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Degree of Hepatic Fibrosis
2011
Remodeling of junctional complexes during the development of the outer blood-retinal barrier
1997
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
2013
Control of a major pest of forestry, Hylobius abietis, with entomopathogenic nematodes and fungi using eradicant and prophylactic strategies
2013
A Prospective, Randomized Study of Endometrial Telomerase during the Menstrual Cycle
2001
Recreational Exposure to Low Concentrations of Microcystins During an Algal Bloom in a Small Lake
2008
Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease
2011